Prot #CY 6033: A Phase 3, Multi‐Center, Randomized, Double‐blind Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults with Symptomatic Non‐Obstructive Hypertrophic Cardiomyopathy

Project: Research project

Project Details

StatusActive
Effective start/end date10/5/23 → 10/5/26

Funding

  • ICON Clinical Research, LLC (Prot #CY 6033 AMD 2 // Prot #CY 6033 AMD 2)
  • Cytokinetics, Inc. (Prot #CY 6033 AMD 2 // Prot #CY 6033 AMD 2)